Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penpulimab with SCRT and CAPEOX in MSS Rectal Cancer
NCT05576480Phase 2Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Feb 2023
- Primary completion
- Oct 2025
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of penpulimab in rectal cancer, sponsored by Ruijin Hospital. Started Feb 2023; status: recruiting.
02
Drugs
penpulimab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT05576480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05576480.